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Insulin action in the central nervous system reg-
ulates energy homeostasis and glucose metab-
olism. To define the insulin-responsive neurons
that mediate these effects, we generated mice
with selective inactivation of the insulin receptor
(IR) in either pro-opiomelanocortin (POMC)- or
agouti-related peptide (AgRP)-expressing neu-
rons of the arcuate nucleus of the hypothala-
mus. While neither POMC- nor AgRP-restricted
IR knockout mice exhibited altered energy ho-
meostasis, insulin failed to normally suppress
hepatic glucose production during euglycemic-
hyperinsulinemic clamps in AgRP-IR knockout
(IRDAgRP) mice. These mice also exhibited re-
duced insulin-stimulated hepatic interleukin-6
expression and increased hepatic expression
of glucose-6-phosphatase. These results di-
rectly demonstrate that insulin action in POMC
and AgRP cells is not required for steady-state
regulation of food intake and body weight.
However, insulin action specifically in AgRP-
expressing neurons does play a critical role in
controlling hepatic glucose production and
may provide a target for the treatment of insulin
resistance in type 2 diabetes.
INTRODUCTION
In 1855, the French physiologist Claude Bernard demon-
strated that the liver serves as a reservoir for glucose (Ber-
nard, 1855). He also postulated that the central nervous
system (CNS) regulates peripheral glucose metabolism438 Cell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Inbased on the observation that lesioning the floor of the
fourth ventricle in rabbits results in glucosuria (Bernard,
1855). However, this latter idea received little attention un-
til recently, when Obici et al. (2002b) demonstrated in a se-
ries of elegant pharmacological studies that hypothalamic
insulin signaling is required for insulin’s ability to inhibit
hepatic glucose production in euglycemic-hyperinsulinemic
clamps of rats. This and subsequent work have implicated
insulin-stimulated activation of phosphatidylinositol 3-
kinase (PI3 kinase) signaling and the regulation of ATP-
dependent potassium (KATP) channels in this pathway
(Pocai et al., 2005). Nevertheless, these experiments leave
open the question of which specific neurons in these areas
are responsible for mediating insulin’s effect.
Further recent work has indicated that hypothalamic
insulin signaling may play a major role in both type 1 and
type 2 diabetes (Gelling et al., 2006). Moreover, insulin’s
effects on tyrosine phosphorylation of Stat3 and inter-
leukin-6 (IL-6) production by the liver, both of which are
important in the insulin resistance of type 2 diabetes,
have been shown to be mediated by effects of insulin at
the level of brain (Inoue et al., 2006). Hypothalamic insulin
signaling is also reduced in rats with uncontrolled strepto-
zotocin-induced diabetes, and infusion of a PI3 kinase
inhibitor into the third ventricle of these rats significantly
blunts the effect of both acute and chronic insulin treat-
ment (Gelling et al., 2006).
Insulin receptors are widely expressed in the brain, and
the exact neuronal target cell responsible for mediating in-
sulin’s central effect on hepatic glucose production has
not yet been identified. Insulin has been shown to act on
hypothalamic neurons that express the orexigenic neuro-
peptide Y (NPY) and agouti-related peptide (AgRP), as
well as those expressing the anorexigenic neuropeptide
pro-opiomelanocortin (POMC) (Benoit et al., 2002;
Choudhury et al., 2005; Schwartz et al., 1992; Sipols
et al., 1995). Moreover, as neuronal activity is modulatedc.
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POMC/AgRP-Neuron IR Knockout Micevia lactate availability from glial cells, insulin action on glial
cells could indirectly regulate the activity of neurons in-
volved in the control of hepatic glucose production (Mag-
istretti et al., 1999). A previous study has addressed the
role of NPY in the regulation of hepatic glucose produc-
tion. Although i.c.v. application of NPY blunts insulin’s
ability to suppress hepatic glucose production, this type
of pharmacological studies does not allow the delineation
of whether the two pathways are physiologically intercon-
nected or independently regulate hepatic glucose produc-
tion (van den Hoek et al., 2004).
In our previous studies, we employed mice in which the
insulin receptor (IR) was genetically deleted in all CNS
neurons and glial cells by Cre-loxP-mediated recombi-
nation (Bruning et al., 2000). These neuron-specific IR
knockout (NIRKO) mice demonstrated diet-sensitive obe-
sity and insulin resistance. Furthermore, insulin failed to
efficiently suppress hepatic glucose production during
euglycemic-hyperinsulinemic clamps (Inoue et al., 2006),
demonstrating that functional IR signaling in the CNS is
a prerequisite for peripherally applied insulin to suppress
hepatic glucose production. To precisely define the neu-
ronal populations mediating insulin’s central effects on
energy and glucose homeostasis, we have now specifi-
cally inactivated the insulin receptor gene in POMC- and
AgRP-expressing neurons of mice.
RESULTS
Generation of IRDPOMC and IRDAgRP Mice
To investigate the role of AgRP- and/or POMC-expressing
neurons, we inactivated the IR gene specifically in each of
these neurons by crossing IRlox/lox mice with mice ex-
pressing Cre recombinase under control of either the
AgRP or the POMC promoter (Balthasar et al., 2004;
Kaelin et al., 2004; Xu et al., 2005a). Cre-mediated recom-
bination was visualized by the use of a reporter mouse
strain in which transcription of the b-galactosidase gene
(LacZ) under the control of the ubiquitously expressed
Rosa26 promoter is prevented by a floxed hygromycin
resistance gene (RosaArte1) (Seibler et al., 2003). These
mice showed a pattern of LacZ immunoreactivity in the
arcuate nucleus (ARC) of the hypothalamus similar to
that of POMC and AgRP (Figures 1A and 1B). Consistent
with restricted inactivation of the IR in defined subpop-
ulations of hypothalamic neurons, western blot analysis
revealed no alterations in overall brain and hypothalamic
IR protein expression (Figure 1C). Similarly, IR expression
in peripheral tissues including liver, muscle, and pancreas
remained unchanged in IRDPOMC and IRDAgRP mice
(Figure 1C). Furthermore, insulin-stimulated Akt phos-
phorylation occurred normally in liver and muscle of
IRDPOMC and IRDAgRP mice as compared to controls (see
Figure S1 in the Supplemental Data available with this
article online).
In harmony with the expression pattern of endoge-
nously expressed POMC, the only nonhypothalamic site
of recombination detectable in PomcCre transgenic
mice was the pituitary gland (Janoschek et al., 2006).CHowever, this did not have any effect on the stress re-
sponse of IRDPOMC mice. Thus, restraint-stress-induced
increases in plasma corticosterone concentrations were
similar in control and IRDPOMC mice (Figure S2), indicating
that IR expression is not required for the control of anterior
pituitary corticotrope cells.
Moreover, since NIRKO mice exhibit hypogonadism,
we also assessed parameters of fertility in IRDPOMC and
IRDAgRP mice. This revealed no significant differences con-
cerning litter-to-litter intervals, litter size, and morphology
of reproductive organs between control, IRDPOMC, and
IRDAgRP mice, indicating that IR signaling in these neurons
is not required for control of fertility (Figure S3).
We next determined the functional effects of POMC-
and AgRP-neuron-restricted IR deficiency on insulin’s
ability to activate the PI3 kinase pathway in control,
IRDPOMC, and IRDAgRP LacZ reporter mice. In the basal
state, little immunoreactive phosphatidylinositol 3,4,5-
triphosphate (PIP3) was detectable in POMC, AgRP, and
adjacent neurons of control, IRDPOMC, and IRDAgRP LacZ
reporter mice. In control mice, insulin treatment resulted
in profound activation of PIP3 formation in POMC-,
AgRP-, non-POMC-, and non-AgRP-expressing neurons
of the ARC (Figures 2A–2F). In contrast, in IRDPOMC and
IRDAgRP mice, insulin stimulation resulted in PIP3 formation
in non-POMC- and non-AgRP cells, but it failed to activate
PIP3 formation in POMC and AgRP neurons (Figures 2A–
2F). These data indicate efficient and specific IR inactiva-
tion in POMC cells of IRDPOMC mice and AgRP cells of
IRDAgRP mice.
Insulin Hyperpolarizes AgRP Neurons
via KATP-Channel Activation
Insulin has been shown to reduce the electrical activity of
unidentified hypothalamic neurons (Spanswick et al.,
2000) as well as identified POMC neurons (Plum et al.,
2006) via activation of KATP channels, and blockade of
central KATP channels abrogates insulin’s ability to inhibit
hepatic glucose production (Obici et al., 2002b; Pocai
et al., 2005). We therefore examined insulin’s ability to
modulate membrane potential and action-potential fre-
quency in POMC and AgRP neurons of control, IRDPOMC,
and IRDAgRP mice using a reporter mouse strain in which
transcription of a green fluorescent protein (GFP) gene
under control of the ubiquitously expressed Rosa26
promoter is prevented by a floxed neomycin resistance
gene (Z/EG) (Novak et al., 2000). Consistent with previous
reports (Plum et al., 2006), insulin caused membrane hy-
perpolarization and reduced the firing frequency of identi-
fied POMC neurons in control mice (Figures S4A–S4C). In
total, 4 out of 9 identified control POMC neurons were hy-
perpolarized after addition of insulin. In contrast, insulin
had no effect on POMC neurons of IRDPOMC mice, while
basal firing rate appeared to be lower in these cells (Fig-
ures S4A–S4C). These data demonstrate the efficiency
of IR inactivation in IRDPOMC mice and show that insulin
stimulates POMC-neuron hyperpolarization by direct in-
teraction with IRs on POMC neurons.ell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Inc. 439
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POMC/AgRP-Neuron IR Knockout MiceFigure 1. Generation of POMC- and AgRP-Specific IR Knockout Mice
(A) Cre-mediated recombination was visualized by immunohistochemistry for b-galactosidase (b-gal) in brains of double-heterozygous reporter mice
(PomcCre-LacZ) at the age of approximately 10 weeks. Blue (DAPI), DNA; green, b-gal (POMC neurons). Scale bar = 100 mm.
(B) Cre-mediated recombination was visualized by immunohistochemistry for b-galactosidase (b-gal) in brains of double-heterozygous reporter mice
(AgRPCre-LacZ) at the age of approximately 10 weeks. Blue (DAPI), DNA; green, b-gal (AgRP neurons). Scale bar = 100 mm.
(C) Western blot analysis of IR-b subunit, Akt, and a-tubulin (loading control) in whole brain, hypothalamus, liver, skeletal muscle, and pancreas in
control, IRDPOMC, and IRDAgRP mice (n = 3 in each group).We performed similar experiments in identified AgRP
neurons of control and IRDAgRP mice. Consistent with the
idea that AgRP cells also express KATP channels (van
den Top et al., 2004), insulin hyperpolarized AgRP cells
of control mice and reduced their action-potential fre-
quency (Figures 3A–3C). In total, 9 out of 9 identified con-
trol AgRP neurons were hyperpolarized after addition of
insulin. In contrast, insulin failed to alter either membrane
potential or action-potential frequency in all AgRP neurons
tested from IRDAgRP mice (Figures 3A–3C), indicating that
the insulin-induced hyperpolarization and changes in
action-potential frequency of AgRP neurons are directly
mediated by the IRs on these cells. Thus, abrogation of in-
sulin signaling had been successfully achieved in AgRP
cells of IRDAgRP mice. Consistent with the finding that inac-
tivation of POMC neurons by insulin occurs via KATP-channel
activation (Plum et al., 2006), application of the KATP-
channel blocker tolbutamide reversed the insulin-induced
hyperpolarization in identified AgRP cells of control mice,
indicating that the same mechanism reported for POMC
neurons also holds true for AgRP neurons (Figure 3D).440 Cell Metabolism 5, 438–449, June 2007 ª2007 Elsevier INormal Body Weight in IRDPOMC and IRDAgRP Mice
To determine the importance of IR signaling in POMC and
AgRP cells in the regulation of energy homeostasis, we
first monitored the body weight of control, IRDPOMC, and
IRDAgRP mice from weaning until 4 months of age. Surpris-
ingly, this revealed no differences in body weight between
the three types of male mice on standard diet (Figures 4A
and 4B), and all three genotypes responded to high-fat
diet with similar increases in weight gain (Figures S5A
and S5B). Consistent with these findings, circulating se-
rum leptin concentrations were indistinguishable between
control, IRDPOMC, and IRDAgRP mice on standard diet, and
all increased to the same extent on high-fat diet (Figures
4C and 4D). Interestingly, both IRDPOMC and IRDAgRP
mice showed food intake similar to control mice (Figures
4E and 4F). Body weight, serum leptin concentrations,
and food intake were also unaltered in female mice on
both normal and high-fat diet (Figures S6A–S6H). Further-
more, male and female IRDPOMC and IRDAgRP mice showed
unaltered relative (corrected for body weight) fat-pad
weight on both normal and high-fat diet as compared tonc.
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POMC/AgRP-Neuron IR Knockout MiceFigure 2. PIP3 Formation in Hypothalamic Neurons of Control, IR
DPOMC, and IRDAgRP Reporter Mice
(A) Double immunohistochemistry of ARC neurons of control and IRDPOMC reporter mice was performed in overnight-fasted animals, which were
intravenously injected with either saline or insulin and sacrificed 10 min after stimulation. Arrows indicate one POMC and one non-POMC neuron
in each panel. Blue (DAPI), DNA; red, b-gal (POMC neurons); green, PIP3.
(B) Quantification of PIP3 levels in control reporter mice in the basal state () and after insulin stimulation (+). Values are means ± SEM of sections
obtained from three unstimulated and four insulin-stimulated control mice. **p% 0.01.
(C) Quantification of PIP3 levels in IR
DPOMC reporter mice in the basal state () and after insulin stimulation (+). Values are means ± SEM of sections
obtained from three unstimulated and three insulin-stimulated IRDPOMC mice.
(D) Double immunohistochemistry of ARC neurons of control and IRDAgRP reporter mice was performed in overnight-fasted animals, which were
intravenously injected with either saline or insulin and sacrificed 10 min after stimulation. Arrows indicate one AgRP and one non-AgRP neuron in
each panel. Blue (DAPI), DNA; red, b-gal (AgRP neurons); green, PIP3.
(E) Quantification of PIP3 levels in control reporter mice in the basal state () and after insulin stimulation (+). Values are means ± SEM of sections
obtained from two unstimulated and two insulin-stimulated control mice. *p% 0.05.
(F) Quantification of PIP3 levels in IR
DAgRP reporter mice in the basal state () and after insulin stimulation (+). Values are means ± SEM of sections
obtained from one unstimulated and four insulin-stimulated IRDAgRP mice.
(G) Examples of different magnitudes of PIP3 immunoreactivity as described in Experimental Procedures.controls (Figures S7A– S7D). Taken together, these data
indicate that energy homeostasis in mice is unaffected
by selective, targeted disruption of the IR gene in POMC
or AgRP neurons of the ARC and that the effects observed
in the global brain knockout, as well as in the studies using
infusion of pharmacological IR inhibitors into the hypothal-
amus or the third ventricle, involve either other centers or
some interaction between different classes of neurons.
Expression of anorexigenic neuropeptides (e.g., POMC)
and orexigenic neuropeptides (such as NPY and AgRP)did not differ between IRDPOMC and control mice
(Figure 4G). As expected since insulin suppresses NPY
and AgRP expression (Kitamura et al., 2006; Schwartz
et al., 1992), IRDAgRP mice did exhibit a slight increase in
AgRP expression (Figure 4H). Nevertheless, this slight
increase apparently is not sufficient to result in significant
alterations of energy homeostasis under steady-state
conditions. Body length was also indistinguishable be-
tween control and conditional IR knockout mice, a further
indication of the intact function of the melanocortinCell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Inc. 441
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POMC/AgRP-Neuron IR Knockout MiceFigure 3. Effects of Insulin and Tolbuta-
mide on Electrical Activity of Control
and IRDAgRP-Z/EG Neurons
(A) Representative recordings of identified
AgRP neurons in ARC slices from AgRPCre-
Z/EG (control) and IRDAgRP-Z/EG mice before
and after addition of 200 nM insulin.
(B) Mean membrane potential of identified
AgRP neurons in ARC slices from AgRPCre-
Z/EG (n = 6) and IRDAgRP-Z/EG (n = 6) mice
before () and after (+) addition of 200 nM
insulin. Displayed values are means ± SEM.
***p% 0.001.
(C) Mean firing frequency of AgRPCre-Z/EG
(n = 6) and IRDAgRP-Z/EG (n = 6) neurons before
() and after (+) addition of 200 nM insulin
(control versus IRDAgRP before addition of in-
sulin, p = 0.11).
(D) Representative recording of an identified
AgRP neuron in an ARC slice from an
AgRPCre-Z/EG (control) mouse in the absence
of drug, after addition of 200 nM insulin, and
after addition of 200 mm tolbutamide.pathway despite the absence of IR signaling in either
POMC or AgRP neurons (Figure S8).
IRDAgRP Mice Fail to Fully Suppress Hepatic Glucose
Production
Since global IR knockout in brain and pharmacological
studies had demonstrated effects on glucose homeosta-
sis and hepatic glucose production, we assessed these
parameters in control, IRDPOMC, and IRDAgRP mice. Blood
glucose and serum insulin concentrations were indistin-
guishable between male (Figures S9A–S9D) and female
(Figures S6I–S6L) IRDPOMC and IRDAgRP mice as compared
to controls. Moreover, glucose tolerance tests revealed no
major disturbance of glucose homeostasis in either of the
knockout mice on either standard diet or high-fat diet
(Figures S9E–S9H).
Since the contribution of individual tissues is impossible
to assess by standard glucose and insulin measurements,
euglycemic-hyperinsulinemic clamps were performed on
the three different groups of mice at 15 weeks of age. After
an overnight fasting period (basal state), mice received
a constant infusion of insulin to produce hyperinsulinemia
and a variable infusion of glucose to maintain euglycemia
over a steady-state period of 30 min. Coadministration of
D-[3-3H]- and 2-deoxy-D-[1-14C]glucose enables the rate
of glucose production under basal and hyperinsulinemic
steady-state conditions to be measured, as well as allow-
ing the rate of insulin-stimulated tissue-specific glucose
uptake to be determined. We found that the glucose infu-
sion rate required to maintain euglycemia during steady-
state conditions, which indicates the balance between
the rates of glucose production and glucose utilization
when insulin is high, was comparable between the differ-442 Cell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Inc.ent groups (Figures 5A and 5B). Steady-state serum
insulin levels were indistinguishable between control,
IRDPOMC, and IRDAgRP mice (Figure S10). Hepatic glucose
production was also not significantly different between the
three groups of mice under basal conditions. However,
whereas control and IRDPOMC mice significantly sup-
pressed hepatic glucose production during steady-state
conditions (Figure 5C), insulin did not significantly reduce
hepatic glucose production in IRDAgRP mice (Figure 5D).
Thus, insulin action on AgRP neurons is required for the
ability of peripherally applied insulin to efficiently suppress
hepatic glucose production.
Determination of tissue-specific glucose uptake rates
showed similar rates of insulin-stimulated glucose uptake
in brain and skeletal muscle in the different groups of mice
(Figure 5E). However, insulin-stimulated glucose uptake in
white adipose tissue of IRDAgRP mice (but not IRDPOMC
mice) was significantly increased compared to control
mice (Figure 5E). A similar increase in adipose glucose up-
take has been observed in mice with selective inactivation
of the IR in skeletal muscle (Bruning et al., 1998). Whether
this represents some form of compensatory response or
tissue crosstalk remains to be determined.
Reduced Hepatic IL-6 Expression in IRDAgRP Mice
It has recently been shown that insulin, acting through the
CNS, induces hepatic IL-6 expression and activates Stat3
in liver parenchymal cells, thereby suppressing hepatic
gluconeogenesis (Inoue et al., 2006). To further investi-
gate the molecular mechanism underlying the failure of
IRDAgRP mice to efficiently suppress hepatic glucose pro-
duction, we determined IL-6 mRNA expression in the liver
of the different groups of mice under basal and clamp
Cell Metabolism
POMC/AgRP-Neuron IR Knockout MiceFigure 4. Unaltered Energy Homeostasis
in IRDPOMC and IRDAgRP Mice
(A) Average body weights of male control
(>) and IRDPOMC (A) mice on normal diet
(n = 26–31).
(B) Average body weights of male control
(>) and IRDAgRP (A) mice on normal diet
(n = 18–25).
(C) Serum leptin levels of male control (n = 10)
and IRDPOMC (n = 10) mice on normal diet (ND)
and high-fat diet (HFD) at 15 weeks of age.
Displayed values are means ± SEM.
(D) Serum leptin levels of male control (n =
11–15) and IRDAgRP (n = 8–15) mice on normal
diet (ND) and high-fat diet (HFD) at 15 weeks
of age.
(E) Daily food intake of male control (n = 15) and
IRDPOMC (n = 20) mice on normal diet at 11–13
weeks of age.
(F) Daily food intake of male control (n = 11) and
IRDAgRP (n = 11) mice on normal diet at 11–13
weeks of age.
(G) Neuropeptide expression in male control
(n = 8) and IRDPOMC (n = 12) mice at 12 weeks
of age.
(H) Neuropeptide expression in male control
(n = 8) and IRDAgRP (n = 8) mice at 12 weeks
of age.steady-state conditions. This revealed a 30% reduction of
steady-state hepatic IL-6 expression in IRDAgRP mice
(Figure 6A), whereas basal IL-6 expression levels were
unaltered between the different groups (Figure S11A).
Concomitantly, clamp steady-state expression of the
glucose-6-phosphatase protein (G6Pase), a key enzyme
of gluconeogenesis, was significantly greater in liver of
IRDAgRP mice than in control and IRDPOMC mice (Figure 6B).
On the other hand, basal expression of G6Pase was unal-
tered in liver of IRDAgRP mice as compared to control and
IRDPOMC mice (Figure S11B). Additionally, determination
of mRNA expression levels of various cytokines and
chemokines in liver of the different groups of mice under
clamp steady-state conditions revealed no significant
differences between control, IRDPOMC, and IRDAgRP mice
(Figure S12).
Taken together, these data indicate that IRDAgRP mice
fail to suppress hepatic glucose production efficiently.
This is paralleled by impaired insulin-stimulated hepatic
IL-6 expression and a failure to suppress expression of
the glucose-6-phosphatase protein.
DISCUSSION
Our results identify directly the target neurons responsible
for the central actions of insulin on hepatic glucose pro-duction. We and others have previously demonstrated
that AgRP neurons play a critical role in the maintenance
of energy and glucose homeostasis (Gropp et al., 2005;
Luquet et al., 2005). Although acute ablation of AgRP neu-
rons in adult mice resulted in hypoglycemia in these
experiments, it was not possible to determine the role
of AgRP neurons in glucose homeostasis since these
animals also exhibit severe cachexia from complete
suppression of food intake. In contrast, POMC- or
AgRP-neuron-restricted inactivation of the IR does not
interfere with the regulation of food intake or energy
homeostasis under normal conditions, thus allowing de-
termination of direct effects on other tissues.
Strikingly, our results further indicate that IR expression
in neurons other than, or in addition to, POMC or AgRP
cells is required for insulin’s ability to control energy
homeostasis. Earlier studies put particular emphasis on
the regulation of NPY and AgRP expression by insulin in in-
sulin’s ability to regulate food intake (Schwartz and Porte,
2005; Schwartz et al., 1992). Although IRDAgRP mice show
a slight increase in AgRP mRNA expression and AgRP
neurons are essential for the maintenance of energy ho-
meostasis, our experiments reveal that lack of insulin-stim-
ulated AgRP and/or NPY regulation can be physiologically
compensated for when signaling by other hormonal or nu-
tritional mediators is intact.Cell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Inc. 443
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POMC/AgRP-Neuron IR Knockout MiceFigure 5. Regulation of Glucose Homeo-
stasis in IRDPOMC and IRDAgRP Mice
(A) Blood glucose levels during the clamp
period in control (,, n = 13), IRDPOMC (-, n =
9), and IRDAgRP (:, n = 11) mice at 15 weeks
of age. Displayed values are means ± SEM.
(B) Glucose infusion rates during the clamp
period in control (,, n = 13), IRDPOMC (-,
n = 9), and IRDAgRP (:, n = 11) mice at 15
weeks of age.
(C) Hepatic glucose production (HGP) mea-
sured under basal and steady-state conditions
during the clamp in control (n = 13), IRDPOMC
(n = 9), and IRDAgRP (n = 11) mice. *p % 0.05;
**p% 0.01.
(D) Percentage suppression of HGP by insulin
as measured under steady-state conditions
during the clamp in control (n = 13), IRDPOMC
(n = 9), and IRDAgRP (n = 11) mice.
(E) Tissue-specific insulin-stimulated glucose
uptake rates in control (n = 13), IRDPOMC
(n = 9), and IRDAgRP (n = 11) mice.Our findings contrast with the hyperphagia found in
mice with CNS-wide inactivation of the IR or in rats in
which IR expression in the ARC and the paraventricular
nucleus (PVN) of the hypothalamus has been downregu-
lated by antisense mRNA (Bruning et al., 2000; Obici
et al., 2002a). They provide direct evidence that neurons
other than AgRP and POMC mediate insulin’s ability to
suppress food intake. This is consistent with the recent
suggestion that leptin’s effects in the ventromedial hypo-
thalamus play an important role in controlling food intake
(Dhillon et al., 2006). Another potential contributing factor444 Cell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Incto the difference between NIRKO, IRDAgRP, and IRDPOMC
mice may be that NIRKO mice also suffer from hypogo-
nadism (Bruning et al., 2000). IRDAgRP and IRDPOMC mice
exhibit normal fertility as assessed by litter-to-litter intervals,
litter size, and morphological assessment of reproductive
organs. Thus, in addition to IR inactivation occurring in
other neurons responsible for regulation of food intake,
hypogonadism may be a confounding factor for the mild,
gender-specific obesity in NIRKO mice.
The finding that AgRP neurons mediate insulin’s central
effect on hepatic glucose production is consistent bothFigure 6. Insulin Action in AgRPNeurons
Regulates Hepatic IL-6 and G6Pase
Expression
(A) IL-6 mRNA expression in liver at the end of
euglycemic-hyperinsulinemic clamps in con-
trol (n = 13), IRDPOMC (n = 9), and IRDAgRP (n =
11) mice. Displayed values are means ± SEM.
**p% 0.01; ***p% 0.001.
(B) Top panel shows western blot analysis of
the glucose-6-phosphatase a subunit and
b-actin (loading control) in liver at the end of
euglycemic-hyperinsulinemic clamps in con-
trol (n = 4), IRDPOMC (n = 5), and IRDAgRP (n = 4)
mice. Bottom panel shows densitometric
analysis of glucose-6-phosphatase a subunit
expression in IRDPOMC and IRDAgRP mice as
compared to controls..
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POMC/AgRP-Neuron IR Knockout MiceFigure 7. Model of HGP Regulation via Insulin Action in AgRP Neurons
Cell-autonomous action of insulin on AgRP neurons results in activation of the PI3 kinase (p85, regulatory subunit; p110, catalytic subunit) and gen-
eration of PIP3. PIP3 activates KATP channels, resulting in hyperpolarization and a decreased neuronal firing rate with subsequent reduced release of
AgRP and other transmitters of AgRP neurons. This regulates innervation of liver, leading to increased IL-6 expression. IL-6 acting on liver parenchy-
mal cells results in Stat3 phosphorylation via activation of Jak2, thereby leading to decreased expression of G6Pase. G6P, glucose-6-phosphate;
gp130, glycoprotein 130; IL-6R, interleukin-6 receptor a; Jak, Janus kinase 2; PIP2, phosphatidylinositol 4,5-biphosphate; Pten, phosphatase and
tensin homolog.anatomically and mechanistically with previous investiga-
tions. Obici et al. (2002a) have demonstrated that injection
of IR antisense mRNA specifically into the third ventricle of
rats or inactivating IR expression in the mediobasal hypo-
thalamus inhibits insulin’s ability to suppress hepatic
glucose production. Although inactivation of the IR colo-
calized with AgRP and POMC neurons in these studies,
they left open the question of whether insulin’s central ef-
fect in regulating hepatic glucose production is mediated
by POMC, AgRP, other ARC, or PVN neurons. Therefore,
cell-type-specific ablation of signaling components in the
hypothalamus provides a definitive approach to unravel
the functional significance of the recently recognized
action of the hypothalamus in controlling glucose meta-
bolism independently of body weight. The feasibility of
this approach has also been revealed by the insights
gained from cell-type-specific ablation or restoration of
leptin and melanocortin signaling (Balthasar et al., 2005;
Dhillon et al., 2006).
Moreover, Obici et al. showed that insulin’s ability to
suppress hepatic glucose production depends on insu-
lin-stimulated activation of the PI3 kinase pathway and
can be inhibited by KATP-channel blockers (Obici et al.,
2002b; Pocai et al., 2005). These findings are consistent
with both our present study and our previous report that
insulin inhibits electrical activity of POMC neurons by
PIP3-dependent opening of KATP channels (Plum et al.,
2006).
Here, we also directly show that insulin treatment leads
to membrane hyperpolarization and a decrease in action-Cpotential frequency in identified hypothalamic AgRP neu-
rons and that this effect involves the activation of KATP
channels. Consistent with the fact that insulin activates
PI3 kinase in AgRP cells (Xu et al., 2005b) (Figure 2) and
that these cells express KATP channels (Spanswick et al.,
2000), we directly demonstrate that the mechanism by
which insulin acts in POMC cells also holds true for
AgRP neurons. Therefore, we propose that insulin acti-
vates PI3 kinase in AgRP cells and that subsequent PIP3
formation results in KATP-channel activation and electrical
silencing of these cells (Figure 7). This leads to reduced re-
lease of the inverse melanocortin receptor agonist AgRP,
NPY, and other transmitters from AgRP neurons and
thereby regulates innervation of the liver, thus suppressing
hepatic glucose production (Figure 7). Our findings also
provide direct evidence in support of the recent idea that
insulin, acting through the CNS, regulates hepatic IL-6
expression to control gluconeogenesis via Stat3 activa-
tion in liver parenchymal cells (Inoue et al., 2006). The
fact that both insulin-induced IL-6 mRNA expression and
suppression of G6Pase expression are blunted in mice
lacking the IR specifically in AgRP neurons indicates that
insulin action on AgRP neurons is responsible for regulat-
ing this signaling cascade (Figure 7).
Although we did not detect a difference in glucose levels
in IRDAgRP mice, both fasting glucose and glucose during
tolerance testing represent an integration of production
and utilization. Our studies demonstrate that insulin action
in AgRP neurons is essential for insulin-induced suppres-
sion of hepatic glucose production.ell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Inc. 445
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type 2 diabetes mellitus in Western populations, our find-
ings raise the possibility that dysregulation of the insulin-
AgRP pathway may contribute to the development of
this disease. Further studies will be needed to determine
whether modulation of AgRP-neuron-mediated regulation
of hepatic glucose production could provide an approach
to support therapeutic control of insulin resistance in type
2 diabetes mellitus.
EXPERIMENTAL PROCEDURES
Animal Care
Care of all animals was within institutional animal care committee
guidelines, and all procedures were approved by local government
authorities (Bezirksregierung Ko¨ln) and were in accordance with NIH
guidelines. Mice were housed in groups of three to five at 22C–
24C using a 12 hr light/12 hr dark cycle with lights on at 6 a.m. Animals
were fed either a regular chow diet (Harlan Teklad Global Rodent
#T.2018.R12) containing 53.5% carbohydrates, 18.5% protein, and
5.5% fat (12% of calories from fat) or a high-fat diet (Altromin
#C1057) containing 32.7% carbohydrates, 20% protein, and 35.5%
fat (55.2% of calories from fat). Animals were given ad libitum access
to water at all times, and food was only withdrawn if required for an
experiment.
Generation of IRDPOMC and IRDAgRP Mice
AgRPCre (Kaelin et al., 2004; Xu et al., 2005a) and PomcCre mice
(Balthasar et al., 2004) were mated with IRlox/lox mice, and breeding
colonies were maintained by mating IRlox/lox mice with AgRPCre-
IRlox/lox (IRDAgRP) and PomcCre-IRlox/lox (IRDPOMC) mice, respectively.
IRlox/lox mice had been backcrossed for at least five generations on
a C57BL/6 background, and AgRPCre and PomcCre mice (initially
established on an FVB background) had been backcrossed for two
generations on a C57BL/6 background before intercrossing them
with IRlox/lox mice. Only animals from the same mixed background
strain generation were compared to each other. Mice were genotyped
by PCR using genomic DNA isolated from tail tips. AgRPCre primers:
AgRPCre 50: 50-CCCTAAGGATGAGGAGAGAC-30; Cre-intern-rev-30:
50-ATGTTTAGCTGGCCCAAATGT-30; AgRP-Intron: 50-ACACCCACC
ATGCACCAAGT-30; PomcCre primers: N16R: 50-TGGCTCAATGTC
CTTCCTGG -30; N57R: 50-CACATAAGCTGCATCGTTAAG-30; AA03:
50-GAGATATCTTTAACCCTGATC-30; IR-30: 50-CTGAATAGCTGA
GACCACAG-30; IR-50: 50-GATGTGCACCCCATGTCTG-30; IR-D-50:
50-GGGTAGGAAACAGGATGG-30.
Glucose Tolerance Tests
Glucose tolerance tests were performed with 16- to 17-hr-fasted
animals. After determination of fasted blood glucose levels, each
animal received an intraperitoneal injection of 20% glucose (10 ml/kg)
(DeltaSelect). Blood glucose levels were measured after 15, 30, 60,
and 120 min.
Body Weight, Food Intake, and Body Length
Body weight was measured once a week; food intake was measured
over 3 weeks in a regular cage using racks, which were weighed
once a week; and daily food intake was calculated as the average in-
take of chow within the time stated. At the end of the study period of 15
weeks, animals were sacrificed via isoflurane anesthesia, and relevant
organs were extracted and stored at 80C until further preparation.
Restraint Stress
Restraint-stress tests were performed as previously described
(Janoschek et al., 2006).446 Cell Metabolism 5, 438–449, June 2007 ª2007 Elsevier IncFertility Assessment
IRlox/lox (control), IRDPOMC, and IRDAgRP females were bred with
IRDPOMC, IRDAgRP, and IRlox/lox (control) males, respectively. Mean litter
size and litter intervals were assessed over at least three litters. For
histological examination, ovaries and testes of 15-week-old animals
were dissected, fixed overnight in 7% formaldehyde, and embedded
in paraffin. Subsequently, 7 mm thick sections were deparaffinized
and stained using hematoxylin and eosin (H&E) for general histology.
Analytical Procedures
Blood glucose values were determined from whole venous blood using
an automatic glucose monitor (GlucoMen Glyco´, A. Menarini Diagnos-
tics). Serum insulin and leptin levels and corticosterone concentration
in plasma were measured by ELISA using mouse standards according
to manufacturer guidelines (Mouse Leptin ELISA and Mouse/Rat Insu-
lin ELISA, Crystal Chem Inc.; Insulin Mouse Ultrasensitive ELISA, DRG
Instruments GmbH; Mouse Leptin Immunoassay, Quantikine; Cortico-
sterone Enzyme Immunoassay Kit, Assay Designs Inc.). For evaluation
of steady-state clamped insulin serum levels, an ultrasensitive insulin
ELISA for determination of human insulin was performed according
to the manufacturer’s guidelines (Ultrasensitive ELISA, #EIA-2337,
DRG Instruments GmbH).
Western Blot Analysis
Indicated tissues were dissected and homogenized in homogenization
buffer with a polytron homogenizer (IKA Werke), and western blot
analyses were performed as previously described (Schubert et al.,
2004) with antibodies raised against IR-b (#sc-711, Santa Cruz), Akt
(#9272, Cell Signaling), phospho-Akt (#4056, Cell Signaling), and
a-tubulin (#T6074, Sigma) as a loading control. For clamp studies,
antibodies were raised against G6Pase-a (#sc-25840, Santa Cruz)
and b-actin (#A5441, Sigma) as a loading control.
Insulin Signaling
Mice were anesthetized by intraperitoneal injection of Avertin (tribro-
moethyl alcohol and tert-amyl alcohol, Sigma-Aldrich), and adequacy
of the anesthesia was ensured by loss of pedal reflexes. The abdom-
inal cavity of the mice was opened, and 125 ml samples containing
5 units regular human insulin (Actrapid, Novo Nordisk) diluted in 0.9%
saline were injected into the inferior vena cava. Sham injections were
performed with 125 ml of 0.9% saline. Samples of liver and skeletal
muscle were harvested 2 and 5 minutes after injection, respectively,
and proteins were extracted from tissues for western blot analysis.
RNA Isolation and Expression Studies
Measurements of mRNA levels were carried out by quantitative RT-
PCR on RNA extracted from dissected tissue. Total RNA was quanti-
fied by spectrophotometry after purification using peqGOLD TriFast
(PEQLAB). Two hundred nanograms of each total RNA was reversely
transcribed with EuroScript reverse transcriptase (Eurogentec) and
amplified using TaqMan Universal PCR Master Mix, No AmpErase
UNG with TaqMan Assay-on-Demand kits (Applied Biosystems),
with the exception of the detection of POMC mRNA, for which custom-
ized primers were used: sense 50-GACACGTGGAAGATGCCGAG-30;
antisense, 50-CAGCGAGAGGTCGAGTTTGC-30; probe sequence, 50-
FAM-CAACCTGCTGGCTTGCATCCGG-TAMRA-30. Relative expres-
sion of mRNA was determined using standard curves based on
hypothalamic cDNA and liver cDNA, respectively. Samples were
adjusted for total RNA content by TATA-box binding protein (TBP),
transferrin receptor (Tfrc), glucuronidase b (Gusb), and hypoxanthine-
guanine phosphoribosyltransferase (Hprt) RNA quantitative PCR.
Calculations were performed by a comparative cycle threshold (Ct)
method: the starting copy number of test samples was determined
in comparison with the known copy number of the calibrator sample
(ddCt). The relative gene copy number was calculated as 2ddCt.
Quantitative PCR was performed on an ABI Prism 7700 Sequence
Detection System (Applied Biosystems). Assays were linear over four
orders of magnitude..
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Catheter implantation was performed as previously described (Fisher
and Kahn, 2003). Only mice that had regained at least 90% of their
preoperative body weight after 6 days of recovery were included in
the experimental groups. After starvation for 16 hr, awake animals
were placed in restrainers for the duration of the clamp experiment. Af-
ter a bolus infusion (5 mCi) of D-[3-3H]glucose (Amersham Biosciences)
tracer solution, the tracer was infused continuously (0.05 mCi/min) for
the duration of the experiment. At the end of the 50 min basal period,
a blood sample (50 ml) was collected for determination of basal para-
meters. To minimize blood loss, red blood cells were collected by
centrifugation and reinfused after being resuspended in saline. Insulin
(human regular insulin; Novo Nordisk) solution containing 0.1% BSA
(Sigma) was infused at a fixed rate (4 mU/g/min) following a bolus infu-
sion (40 mU/g). Blood glucose levels were determined every 10 min (B-
Glucose Analyzer, HemoCue), and physiological blood glucose levels
(between 120 and 145 mg/dl) were maintained by adjusting a 20% glu-
cose infusion (DeltaSelect). Approximately 60 min before steady state
was achieved, a bolus of 2-deoxy-D-[1-14C]glucose (2DG) (10 mCi,
Amersham) was infused. Steady state was ascertained when glucose
measurements were constant for at least 30 min at a fixed glucose in-
fusion rate and was achieved within 100 to 130 min. During the clamp
experiment, blood samples (5 ml) were collected after infusion of the
2DG at time points 0, 5, 15, 25, 35 min, etc. until reaching the steady
state. During the steady state, blood samples (50 ml) were collected
for the measurement of steady-state parameters. All blood samples
were kept at room temperature until centrifugation; serum samples
were stored at 20C. At the end of the experiment, mice were killed
by cervical dislocation, and brain, liver, white adipose tissue (WAT),
and skeletal muscle were dissected and stored at 80C.
Plasma [3-3H]glucose radioactivity at basal and steady state was
measured as previously described (Fisher and Kahn, 2003). Plasma
deoxy-[1-14C]glucose radioactivity was directly measured in a liquid
scintillation counter. WAT and skeletal muscle lysates were processed
through ion-exchange chromatography columns (Poly-Prep Prefilled
Chromatography Columns, AG1-X8 formate resin, 200–400 mesh
dry; Bio-Rad) to separate 2DG from 2DG-6-phosphate (2DG6P).
For determination of basal G6Pase-a protein and IL-6 mRNA ex-
pression, 16 hr fasted animals were dissected and livers were stored
at 80C until further preparation. Basal and steady-state liver sam-
ples were processed for western blot analysis as described above,
as well as for real-time PCR. Two hundred nanograms of each total
RNA sample was reverse transcribed, and then PCR-amplified using
an ABI Prism 7700 Sequence Detection System. Efficiency of the
primers was estimated from standard curves made with serial cDNA
dilutions.
Glucose turnover rate (mg/kg/min) was calculated as previously de-
scribed (Fisher and Kahn, 2003). In vivo glucose uptake for brain, WAT,
and skeletal muscle (nmol/g/min) based on the accumulation of
2DG6P in the respective tissue and the disappearance rate of 2DG
from plasma was calculated as described previously (Ferre et al.,
1985).
Immunohistochemistry
IRDPOMC and IRDAgRP mice were mated with RosaArte1 reporter mice
(Seibler et al., 2003). IRDPOMC LacZ, IRDAgRP LacZ, and wild-type re-
porter (PomcCre-, AgRPCre-LacZ) mice were anesthetized and trans-
cardially perfused with physiologic saline solution followed by 4%
paraformaldehyde (PFA) in 0.1 M phosphate-buffered saline (PBS;
pH 7.4). Hypothalami were dissected, postfixed in 4% PFA at 4C,
transferred to 20% sucrose for 6 hr, and frozen in tissue freezing
medium. Then, 25 mm thick free-floating coronal sections were cut
through the ARC using a freezing microtome (Leica). The sections
were collected in PBS (pH 7.4) and washed extensively to remove
cryoprotectant. Subsequently, the sections were treated with 0.3%
H2O2 in PBS for 20 min to quench endogenous peroxidase activity.
Following pretreatments, the sections were processed using the TSA
Biotin System (PerkinElmer) according to the manufacturer’s guide-Clines (primary antibody: rabbit anti-LacZ, Cappel; secondary antibody:
peroxidase-labeled goat anti-rabbit, Vector Laboratories).
For determination of the functional effects of neuron-restricted IR
deficiency, IRDPOMC LacZ, IRDAgRP LacZ, and wild-type reporter
(PomcCre-, AgRPCre-LacZ) mice were starved over night, anesthe-
tized, and intravenously injected with either saline or 5 U of human
regular insulin (Novo Nordisk) for 10 min. Mice were then perfused
transcardially with physiologic saline solution, frozen in tissue freezing
medium (Jung), and sectioned on a cryostat. Tissues were stained with
galactosidase (#55976, Cappel) and PIP3 (#Z-G345, Echelon, FITC-
conjugated), and double-fluorescence immunostaining was per-
formed as previously described (Plum et al., 2006). Slides were viewed
through a Zeiss Axioskop equipped with a Zeiss AxioCam for acquisi-
tion of digital images using Spot Advanced 3.0.3 software.
Analysis of PIP3 Formation In Situ
For quantitative analysis of PIP3 levels in POMC neurons, a total of
1812 LacZ-positive neurons were counted in ARC slices of control
mice injected with NaCl (n = 3; 365 POMC neurons), insulin-stimulated
control mice (n = 4; 532 POMC neurons), IRDPOMC mice injected with
NaCl (n = 3; 423 POMC neurons), and insulin-stimulated IRDPOMC
mice (n = 3; 492 POMC neurons). For quantitative analysis of PIP3
levels in AgRP neurons, a total of 673 LacZ-positive neurons were
counted in ARC slices of control mice injected with NaCl (n = 2; 75
AgRP neurons), insulin-stimulated control mice (n = 2; 57 AgRP neu-
rons), IRDAgRP mice injected with NaCl (n = 1; 95 AgRP neurons), and
insulin-stimulated IRDAgRP mice (n = 4; 446 AgRP neurons). The
amount of PIP3 was classified as low (immunoreactive cytoplasmic
dots/sprinkles in the proximity of the nucleus at background levels,
i.e., six or fewer dots, no cloudy aspect, no confluent areas), moderate
(dots/sprinkles at levels above background, i.e., more than six dots,
cloudy aspect), or high (numerous dots/sprinkles, cloudy with con-
fluent areas) (see Figure 2G). Slides were viewed through a Zeiss
Axioskop equipped with a Zeiss AxioCam for acquisition of digital
images. Neurons positive for b-gal were counted and marked digitally
to prevent multiple counts, and PIP3 immunoreactivity was rated as
previously described (Plum et al., 2006) using Zeiss AxioVision version
4.2 imaging software. Results were expressed as percentage of POMC
or AgRP neurons, showing the respective PIP3 levels.
Electrophysiology
Coronal brain slices (250–300 mm) containing the ARC were prepared
from 6-week-oldAgRPCre-Z/EG and IRDAgRP-Z/EGmice. After at least
15 min recovery at 35C in artificial cerebrospinal fluid (ACSF) gassed
with 95% O2 and 5% CO2, brain slices were transferred to a recording
chamber and continuously perfused at 2–4 ml/min with gassed ACSF.
ACSF contained (in mM) 125 NaCl, 21 NaHCO3, 2.5 KCl, 1.2 NaH2PO4,
2 CaCl2, 2 MgCl2, 10 HEPES (pH 7.4), 5 glucose. Brain slices were
viewed with a Zeiss Axioskop fitted with fluorescence and infrared dif-
ferential interference contrast (IR-DIC) videomicroscopy. Fluorescent
AgRP-EGFP neurons were identified by epifluorescence and patched
under IR-DIC optics. Whole-cell current-clamp and voltage-clamp
recordings were made using an EPC-9 patch-clamp amplifier, as pre-
viously described (Burdakov and Ashcroft, 2002; Plum et al., 2006).
Patch pipettes had resistances of 3–5 MU when filled with internal
solution. For most experiments, patch pipettes were filled with internal
solution containing (in mM) 128 K-gluconate, 10 KCl, 10 HEPES
(pH 7.3, adjusted with KOH), 0.1 EGTA, 2 MgCl2, 0.3 Na-GTP, 3 K2-ATP.
The external solution was ACSF in all experiments. Experiments
were carried out at 22C–25C. Data were filtered, sampled with
PULSE/PULSEFIT version 8.67 (HEKA), and analyzed with PULSEFIT
and Origin version 6.0 (Microcal).
Responses to insulin (200 nM, Sigma) in fluorescently labeled POMC
neurons in brain slices from 10-week-old transgenic mice (PomcCre-
Z/EG and IRDPOMC-Z/EG) were assessed by standard whole-cell
patch-clamp recording in the current-clamp mode using Axopatch
200B (Molecular Devices) as previously described (Cowley et al.,ell Metabolism 5, 438–449, June 2007 ª2007 Elsevier Inc. 447
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quency were determined using Mini Analysis (Synaptosoft).
Statistical Methods
Data were analyzed for statistical significance by two-tailed unpaired
Student’s t test.
Supplemental Data
Supplemental Data include 12 figures and can be found with this article
online at http://www.cellmetabolism.org/cgi/content/full/5/6/438/
DC1/.
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